Freedom to Operate Releases Study to Protect the Development of LSD-based Therapies from Unfounded Patent Claims

The non-profit, Freedom to Operate (FTO), has just published new research on the polymorphic form of LSD D-tartrate, a common salt form of LSD.  In furtherance of its mission to advance science and education, specifically research, in the public interest and for the public benefit, this new FTO sponsored study can be used by researchers, patent examiners and others to reject unfounded claims and to fight back against anyone attempting to patent a polymorphic form of LSD and its salts.  In doing so, FTO is taking a critical step to help protect and advance research and the development of LSD-based therapies that may eventually benefit millions of currently underserved patients.